Delayed Cutaneous Reactivity Associated With COVID-19 Vaccines Is Rare

Abstract

Keywords

COVID-19 coronavirus vaccine immunization delayed cutaneous hypersensitivity COVID Arm mRNA-1273 BNT162b2

Get full access to this article

View all access options for this article.

References

Baden

LR.

El Sahly

HM.

Essink

et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403-416.doi:10.1056/NEJMoa2035389

33378609

Blumenthal

KG.

Freeman

EE.

Saff

et al. Delayed large local reactions to mRNA-1273 vaccine against SARS-CoV-2. N Engl J Med. 2021;384(13)-1277.doi:10.1056/NEJMc2102131

33657292

Beveridge

MG.

Polcari

IC.

Burns

JL.

Adler

Hendrickson

Stein

. Local vaccine site reactions and contact allergy to aluminum. Pediatr Dermatol. 2012;29(1):68-72.doi:10.1111/j.1525-1470.2011.01541.x

21854416

Stone

CA.

Rukasin

CRF.

Beachkofsky

TM.

Phillips

. Immune‐mediated adverse reactions to vaccines. Br J Clin Pharmacol. 2019;85(12):2694-2706.doi:10.1111/bcp.14112

31472022

Banerji

Wickner

PG.

Saff

et al. mRNA vaccines to prevent COVID-19 disease and reported allergic reactions: current evidence and suggested approach. J Allergy Clin Immunol Pract. 2021;9(4):1423-1437.doi:10.1016/j.jaip.2020.12.047

33388478